Funded Postdoctoral positions Laboratory of Pierre-Henri Gaillard Cancer Research Center of Marseille (CRCM), France

Our laboratory focuses on understanding how structure-specific DNA endonucleases (SSEs) are controlled and how the SLX4 tumor suppressor contributes to genome stability in ways that rely or not on SSEs.

Available projects will require extensive use of molecular biology techniques, cell culture work and will involve the development of cellular and biochemical functional assays.

The successful candidates are expected to have obtained a Ph.D. in biology, biochemistry or related fields, published at least one first author publication in peer reviewed well established international journal and acquired training in the areas of DNA repair and/or cell-cycle control combined with solid experience in tissue culture and in cell biology and/or biochemistry.

Funding will initially be for 12 months during which the candidate will be encouraged to apply for independent funding. Contingent upon job performance, we will offer 12 months extensions to the initial contract if no independent funding is obtained during the first year.

The CRCM provides a stimulating international working environment. It is located on the campus of the Institut Paoli Calmettes (IPC), one of the prime cancer treatment centers in France, and offers state of the art research facilities and technology platforms. In addition to the IPC, the CRCM is also affiliated to the French governmental research agencies INSERM and CNRS and the Aix- Marseille University.

For more information go to http://crcm.marseille.inserm.fr/en/

As for Marseille, it is a vibrant city with a fascinating historical heritage and a unique geographical localization. For more information on Marseille go to http://www.marseille-tourisme.com/en/discover-marseille/

Applicants should send a detailed CV, along with contact information of at least two references, to Pierre-Henri Gaillard: pierre-henri.gaillard@inserm.fr


Post-doctoral position

Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases (Inserm & Toulouse Paul Sabatier University), Toulouse, France.

The position is open from January 2017 for 1 year.

The scientific program of the post-doctoral fellow aims at analyzing data collected during a clinical protocol, notably gene profiling (microarrays, high throughput RT-qPCR), lipidomics and bio-clinical data from plasma and tissues.

It is part of the Obesity Research Laboratory topics, especially those relevant to nutrition and metabolic health.

We seek a highly motivated scientist with strong background nutrigenomics and knowledge in biostatistics and cell biology. Excellent communication, collaborative and organizational skills are expected. The applicant will be required to provide regular oral and written reports.

The applicant must hold a PhD degree with less than 3 years of experience as post-doctoral fellow. Restrictions may apply to candidates who previously held positions in French institutions.

To apply : please send (before 20th of October) summary of past and current work (no more than one page each), list of publications and CV with names and coordinates of 2 references to: nathalie.viguerie@ inserm.fr

Obesity Research Laboratory

The Obesity Research Laboratory (http://www.i2mc.inserm.fr/d_langin) works on the consequences of the excess of fat mass observed in obesity and aims at understanding the biological determinants and molecular mechanisms of obesity-related metabolic complications with a special emphasis on type 2 diabetes. The laboratory is composed of 23 scientists with backgrounds in cell biology, genomics, animal physiology, medicine, pharmacy and veterinary medicine. Using bedside-to-bench approaches, the main goal is to decipher the cellular and molecular mechanisms associating fatty acid and glucose metabolism at tissue and whole body levels and to evaluate the therapeutic potential of drugs acting on these pathways.

Institute of Metabolic and Cardiovascular Diseases (I2MC)

I2MC is one of the largest Research Centre in metabolic and cardiovascular diseases in Europe with 15 laboratories and a work force of about 300. Basic scientists and clinicians are working on metabolic risk factors (obesity, diabetes and dyslipidemia) and cardiovascular complications (thrombosis, atherosclerosis, cardiac and renal failure). I2MC combines expertise in cell biology, mouse models and clinical work supported by core facilities in lipidomics, genomics, proteomics, animal phenotyping and cell imaging.

www.i2mc.inserm.fr

Toulouse

Toulouse is located in Southwestern France close to the Pyrenees Mountains and Spain with flight and train connections to French and European cities. With more than 100,000 students and praised quality of life, it is ranked as the best place to live and study in France.


Proposition de Doctorat, Toulouse, France

Sujet : Effets génotoxiques et génotoxines bactériennes dans la cancérogenèse colorectale – caractérisation par imagerie en temps réel (projet IDEX-UPS COLiveTox)

Nous cherchons un(e) jeune scientifique fortement motivé(e) pour intégrer notre groupe de recherche dédié à la génotoxicité. Le/la candidat(e) développera un projet concernant l’étude des effets génotoxiques, en particulier liés à l’exposition à une génotoxine bactérienne, dans la cancérogenèse colorectale. Cette étude nécessitera la caractérisation par imagerie en temps réel de ces mécanismes et combinera différentes approches expérimentales (culture cellulaire, biologie moléculaire, biochimie). Ce travail collaboratif implique l’équipe 8 ‘génotoxicité et Signalisation’ de Toxalim (UMR 1331 INRA-INP-UPS, Toulouse) et l’équipe IP3D (ITAV – Centre Pierre Potier CNRS-USR3505, Toulouse). Les compétences attendues relèvent de la biologie cellulaire et moléculaire ainsi que de connaissances en génotoxicologie. Merci d’envoyer votre CV, lettre de motivation et au moins deux lettres et adresses e-mail de referees.

Détails de l’offre

Employeur : INRA (Institut National de la Recherche Agronomique) & ITAV-Centre Pierre Potier Contact : Dr G Mirey gladys.mirey@toulouse.inra.fr Localisation : Equipe Genotoxicity Signaling, Toxalim INRA 180 chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3 http://www6.toulouse.inra.fr/toxalim/Equipes-Recherche/E8-GS-Genotoxicite-Signalisation

Fin de l’appel à candidature : 15 oct. 2016 (début du contrat au plus tard le 1er décembre 2016)

Type d’emploi : doctorant(e), 3 ans, plein temps


Funded Postdoctoral positions

Laboratory of Pierre-Henri Gaillard Cancer Research Center of Marseille (CRCM), France

Our laboratory focuses on understanding how structure-specific DNA endonucleases (SSEs) are controlled and how the SLX4 tumor suppressor contributes to genome stability in ways that rely or not on SSEs.

Available projects will require extensive use of molecular biology techniques, cell culture work and will involve the development of cellular and biochemical functional assays.

The successful candidates are expected to have obtained a Ph.D. in biology, biochemistry or related fields, published at least one first author publication in peer reviewed well established international journal and acquired training in the areas of DNA repair and/or cell-cycle control combined with solid experience in tissue culture and in cell biology and/or biochemistry.

Funding will initially be for 12 months during which the candidate will be encouraged to apply for independent funding. Contingent upon job performance, we will offer 12 months extensions to the initial contract if no independent funding is obtained during the first year.

The CRCM provides a stimulating international working environment. It is located on the campus of the Institut Paoli Calmettes (IPC), one of the prime cancer treatment centers in France, and offers state of the art research facilities and technology platforms. In addition to the IPC, the CRCM is also affiliated to the French governmental research agencies INSERM and CNRS and the Aix- Marseille University. For more information go to http://crcm.marseille.inserm.fr/en/

As for Marseille, it is a vibrant city with a fascinating historical heritage and a unique geographical localization. For more information on Marseille go to http://www.marseille-tourisme.com/en/discover-marseille/

Applicants shouldsend a detailed CV, along with contact information of at least two references, to Pierre-Henri Gaillard: pierre-henri.gaillard@inserm.fr


Proposition de Doctorat, Toulouse, France

Sujet : Effets génotoxiques et génotoxines bactériennes dans la cancérogenèse colorectale – caractérisation par imagerie en temps réel (projet IDEX-UPS COLiveTox)

Nous cherchons un(e) jeune scientifique fortement motivé(e) pour intégrer notre groupe de recherche dédié à la génotoxicité. Le/la candidat(e) développera un projet concernant l’étude des effets génotoxiques, en particulier liés à l’exposition à une génotoxine bactérienne, dans la cancérogenèse colorectale. Cette étude nécessitera la caractérisation par imagerie en temps réel de ces mécanismes et combinera différentes approches expérimentales (culture cellulaire, biologie moléculaire, biochimie). Ce travail collaboratif implique l’équipe 8 ‘génotoxicité et Signalisation’ de Toxalim (UMR 1331 INRA-INP-UPS, Toulouse) et l’équipe IP3D (ITAV – Centre Pierre Potier CNRS-USR3505, Toulouse). Les compétences attendues relèvent de la biologie cellulaire et moléculaire ainsi que de connaissances en génotoxicologie. Merci d’envoyer votre CV, lettre de motivation et au moins deux lettres et adresses e-mail de referees.

Détails de l’offre Employeur :

INRA (Institut National de la Recherche Agronomique) & ITAV-Centre Pierre Potier

Contact : Dr G Mirey gladys.mirey@toulouse.inra.fr Localisation : Equipe Genotoxicity Signaling, Toxalim INRA 180 chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3 http://www6.toulouse.inra.fr/toxalim/Equipes-Recherche/E8-GS-Genotoxicite-Signalisation

Fin de l’appel à candidature : 15 oct. 2016 (début du contrat au plus tard le 1er décembre 2016) Type d’emploi : doctorant(e), 3 ans, plein temps


Boehringer Ingelheim FENS Research Award

The Boehringer Ingelheim FENS Research Award is given in recognition of outstanding and innovative scientific work from all areas of neuroscience research.

Further Information

Funding body:
Federation of European Neuroscience Societies (FENS)
Maximum value:
€ 25,000
Application deadline:
None specified

Extended Description

The Boehringer Ingelheim FENS Research Award is donated by the pharmaceutical company Boehringer Ingelheim and is announced by the Federation of European Neuroscience Societies (FENS). FENS is the main organisation for neuroscience in Europe. FENS was established in 1998 and currently represents over 40 European national and single discipline neuroscience societies with close to 23,000 member scientists from over 30 European countries. Its aim is to promote excellence in neuroscience research and facilitate the exchange and networking between neuroscientists within the European Research Area and beyond.

The Boehringer Ingelheim FENS Research Award is awarded once every two years to recognise outstanding neuroscience research by early- and mid-career European researchers.

Eligibility Criteria

Eligible candidates must be under 40 years of age and either be working in a European institute or be of European origin and working abroad.

Nominations can be submitted by the candidates or candidates may be proposed.

Value Notes

The award consists of a personal prize of €25,000.

Previous Successes

Previous winners include:

  • 2016: Gaia Novarino.
  • 2014: Judit Makara.
  • 2012: Ilka Diester.

Application Procedure

Nominations must be submitted to the Federation of European Neuroscience Societies (FENS).

The nomination deadline for the 2016 award was 31 July 2015. The next call for nominations will be launched in summer 2017.

Learn more


ACTERIA Prizes

The ACTERIA Prizes are awarded by the European Federation of Immunological Societies (EFIS) for the best doctoral theses defended in the last three years, and for the best early career research work of investigators with up to ten year’s postdoctoral experience in the fields of immunology and allergology.

Further Information

Funding body:
European Federation of Immunological Societies (EFIS)
Maximum value:
€ 180,000
Application deadline:
None specified

Extended Description

The ACTERIA Prizes were established in 2012 by the Fondation ACTERIA (ACTing on European Research in Immunology and Allergology) and the European Federation of Immunological Societies (EFIS). EFIS is a non-profit umbrella organisation that represents immunological societies from all across Europe, whereby every active member of any of the member societies is automatically considered an EFIS member and can as such benefit from EFIS-programmes.

Four ACTERIA prizes are awarded every three years: two ACTERIA Doctoral Prizes and the two ACTERIA Early Career Research Prizes.

Eligibility Criteria

Eligible applicants for the ACTERIA Doctoral Prizes are candidates who earned their doctoral degree within the three years before the application deadline of the year the prizes are awarded and who have defended their doctoral thesis in a topic related to immunology and allergology in a European university/institution.

Eligible applicants for the ACTERIA Early Career Research Prizes are young immunologists and allergologists for their achievements and research efforts conducted in a European university/research organisation in the past ten years subsequent to receiving their doctoral degree.

Nominations for the ACTERIA Prizes are to be submitted to EFIS by an EFIS member in good standing.

Additional Information

European countries are defined as those where an immunological or allergological society is affiliated to EFIS.

Value Notes

The ACTERIA Doctoral Prizes consist of a monetary award of €15,000 and the ACTERIA Early Career Research Prizes consist of a monetary award of €30,000.

Furthermore, there is an additional possibility to receive a grant of €50,000 per year for three-year research projects to be performed in European institutions.

Previous Successes

Previous winners include:

  • 2015 Doctoral Prize in Allergology: Sandra Pahr (Medical University of Vienna).
  • 2015 Doctoral Prize in Immunology: Chris Schiering (The Francis Crick Institute – Mill Hill Laboratory, London).
  • 2015 Early Career Research Prize in Allergology: Thomas Marichal (University of Liege).
  • 2015 Early Career Research Prize in Immunology: Dietmar Zehn (Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne).

Application Procedure

Applications must first be submitted to EFIS by providing all required information in the online application form on the ACTERIA Prizes website.

The application must consist of the following documents:

  • Curriculum Vitae with publications, including primary research articles, reviews, book chapters, conference proceedings, oral presentations, etc.
  • Summary of dissertation including a summary of activity since earning the doctoral degree.
  • Letter of reference from doctoral degree supervisor.
  • Proof of Membership in an EFIS-affiliated National Society.
  • Proposed research project including: state-of-the-art, questions addressed, research programme and methods, expected results, feasibility, potential bottlenecks and solutions, if necessary, timeline, short list of references.
  • Letter from the Host Institution where the project will be conducted, confirming that appropriate facilities will be guaranteed to the researcher in the event the project is approved, and including a statement that the safety rules of the organisation will be applied.
  • Ethics statement (applicable for research using human or animal samples or conducted in humans or animals) confirming that the proposed project will be submitted to the appropriate Institutional Review Board/Ethics Committee before funding is awarded by the Fondation ACTERIA.

Following the submission deadline, a candidate’s application will be forwarded to the EFIS-affiliated National Society to which the candidate belongs. Thereafter, the National Societies will review the applications and, based on the quality of proposals, ultimately formulate two nominations, one in immunology and one in allergology, to be formally submitted to the ACTERIA Prizes Selection Jury.

The deadline for the 2015 ACTERIA Prizes was 31 December 2014. The next edition of the ACTERIA Prizes is expected to be organised in 2018.


EFIS – World Fellowship

The World Fellowship funding instrument of the European Federation of Immunological Societies (EFIS) is aimed at building a strong international immunological research network.

Further Information

Funding body:
European Federation of Immunological Societies (EFIS)
Maximum value:
€ 12,000
Application deadline:
28-02-2017

Extended Description

The European Federation of Immunological Societies (EFIS) is a non-profit umbrella organisation established in 1975. It represents immunological societies from all across Europe, whereby every active member of any of the member societies is automatically considered an EFIS member and can as such benefit from EFIS-programs.

Within the framework of the World Fellowship funding instrument, EFIS and Immunology Letters (IL) award long-term fellowships (up to six months) for purposes of scientific collaboration, advanced training or of learning techniques or methods not available in the applicant’s current place of work.

Eligibility Criteria

Eligible applicants are members of an EFIS-affiliated society (exceptions to this may apply only for applicants from European countries without a national society) who are 35 years of age or younger and who hold at least a Master’s degree.

An extension to the age limit of up to 18 months may be granted for maternity/paternity leave, civil or military service, etc.

Fellowships are not renewable and can be held only once.

Additional Information

Three fellowships will be awarded following one call per year.

Value Notes

The grant is €1,750 per month. In addition, EFIS will reimburse travel costs (economy air or second-class train fare) up to a maximum of €1,500.

Restrictions

Fellowships cannot be held simultaneously with awards or funding made available by other sources or organisations, nor can they be used to prolong visits begun under other auspices, or as a means to bridge between research visits funded by other organisations.

Application Procedure

Applications may be submitted to EFIS by providing all required information in the online application form.

The application must consist of the following documents:

  • Short curriculum vitae.
  • List of publications.
  • Project proposal (maximum of two pages). The proposal should include summary and aim, background and operational objectives and working plan.
  • Letter of recommendation (not from the receiving institute).
  • Acceptance letter from the head of receiving Institute.
  • Proof of EFIS membership.

There is one application period per year. The next application deadline is 28 February 2017.


FEMS-ASM Mäkelä-Cassell Award

The award supports the reciprocal exchange of members of the Federation of European Microbiological Societies (FEMS) and the American Society for Microbiology (AMS), to present his/her research at the other organisation’s main conference.

Further Information

Funding body:
Federation of European Microbiological Societies (FEMS)
Maximum value:
Discretionary
Application deadline:
15-12-2016

Extended Description

The Federation of European Microbiological Societies (FEMS) is a membership organisation bringing together 50 member societies from 36 European countries, supporting over 30,000 microbiologists. The Society’s aim is to advance microbiology in Europe by offering research grants and helping to inform and educate through publications, journals, conferences and teaching support.

The FEMS-ASM Mäkelä-Cassell Award is designed to benefit early career scientists from both the Federation of European Microbiological Societies and the American Society for Microbiology (AMS) by giving them the opportunity to present their work overseas and experience the best of microbiology in the partner country. The programme also provides an opportunity for both organisations to become more visible to each other’s membership.

Eligibility Criteria

Eligible FEMS applicants are microbiologists active in research and less than 36 years of age. They should have been members of a FEMS member Society for at least one year before the application deadline.

Eligible ASM applicants are U.S. citizen or permanent residents of the U.S. who are a current member of the American Society for Microbiology. They should be a current PhD (or equivalent) student or recipient of a PhD within the past five years.

Value Notes

The FEMS grant is intended to support travel and living costs of the grantee only.

ASM provides the following:

  • $5000 towards expenses associated with participation in the Biannual FEMS Congress.
  • An economy flight between the U.S. and Europe.
  • FEMS Congress registration.

Terms and Conditions

ASM proposals will be assessed on:

  • Academic excellence of the applicant (CV).
  • Quality and originality of proposed presentation (Abstract).
  • Depth of the applicant’s research experience (Synopsis of Research).

Application Procedure

FEMS applications should be submitted to the FEMS Central Office using the online grant application system. ASM applicants should be submitted via ASM’s online application system.

ASM will select the member attending the biannual FEMS Congress and FEMS will select the member attending the ASM General Meeting occurring in intermittent years when no FEMS Congress is held.

In 2016, ASM applicants may apply. The deadline is 15 December 2016.

The next opportunity for a FEMS member to apply will be for the ASM Congress in 2018.


Science and SciLifeLab Prize for Young Scientists

One Grand Prize and three additional awards for young scientists who have achieved a doctorate over the last two years and whose thesis focused on either Cell and Molecular Biology, Genomics and Proteomics, Ecology and Environment, or Translational Medicine. The Prize includes the opportunity to attend a week of scientific events in Sweden.

Further Information

Funding body:
American Association for the Advancement of Science (AAAS)
Maximum value:
€ 25,900
Application deadline:
01-08-2016

Extended Description

The American Association for the Advancement of Science (AAAS) was founded in 1848 and is the world’s largest general scientific society. Including 254 affiliated academies of science and societies, serving 10 million individuals and the publisher of journals, Science, Science Translational Medicine, Science Signaling and Science Advance, AAAS, it is a non profit organisation that seeks to “advance science and serve society” via science education, policy, international programmes and more. Thomas Edison founded the journal Sciencewhich has the largest paid circulation of any peer reviewed science journal in the world with an estimated total readership of 570,000.

Established in 2010, Science for Life Laboratory (SciLifeLab) is a Swedish national centre for molecular biosciences with focus on health and environmental research. The centre combines frontline technical expertise with advanced knowledge of translational medicine and molecular bioscience. SciLifeLab is a joint effort between four Swedish universities (Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University and Uppsala University).

The annual Science and SciLifeLab Prize for Young Scientists has been created by AAAS and SciLifeLab to demonstrate that global economic health is dependent on encouraging recent graduates to continue in their chosen field of scientific research. Applicants are required to submit an essay on their thesis for a chance to win one of four prizes.

The research described in the entrant’s thesis must fall within one of the following categories (Subject Tracks):

  • Cell and Molecular Biology: Including cellular and molecular processes at levels ranging from single molecule to single cell to tissue and organ systems.
  • Genomics and Proteomics: Focusing on analyses of gene- and protein-related events, at the scale of gene or protein networks to the complete set of genes or proteins in an organism.
  • Ecology and Environment: Encompassing interactions between organisms and their environment, and how these processes are influenced by human activity.
  • Translational Medicine: Building on in vitro or animal model studies of biological processes to develop potential therapies or medical procedures.

Winners from each category will compete for the Grand Prize.

Eligibility Criteria

The prize will be awarded without regard to sex, race, or nationality. Entrants for the 2016 prize must have been awarded their PhD between 1 January 2014 and 31 December 2015.

Additional Information

All four winners will be invited to to take part in a week of scientific events in Stokholm, Sweden. This will include an opportunity to meet with leading researchers in their field and will include an official awards ceremony which takes place in the Grand Hôtel Hall of Mirrors, the original venue of the Nobel prize banquet.

Value Notes

The winning entry will receive a cash prize of $30,000 (approximately £21,022.08).

There are also three additional runner up prizes of $10,000 (approximately £7,007.36).

Restrictions

Employees of SciLifeLab, AAAS, and collaborators in the management or sponsorship of the Prize and their relatives are not eligible to compete.

Terms and Conditions

Essays are judged on the quality of research and the applicant’s ability to articulate how their work would contribute to the scientific field.

Previous Successes

The 2015 prize was awarded to Dr Alison Cleary for her work on cell and molecular biology in relation to tumors.

Dr Liron Bar-Peled was awarded the Grand Prize in 2014 for his research into how mammalian cell size is influenced by its environment.

For his novel research using viral infections in bats to help answer questions about how infectious diseases jump between species, Daniel G. Streicker was named the 2013 Grand Prize winner.

Application Procedure

The deadline for entries is 1 August, 2016.

Candidates are required to create an account with SciLife in order to enter the Prize. The entry form and additional submission materials must be submitted electronically through this system.

Prize winners will be announced in December 2016.